GlassScriptPhysician profile
Trang T Tran
NPI 1891883963
$3,045.27
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $754 · 2023: $374 · 2024: $1,148 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $566.57 | 2021-2023 | Evenity, Repatha, Prolia |
| Oyster Point Pharma, INC. | $370.79 | 2022-2024 | Tyrvaya |
| Scilex Pharmaceuticals INC. | $277.16 | 2024 | |
| Bausch & Lomb Americas INC. | $249.99 | 2024-2025 | Miebo, Xiidra |
| Gilead Sciences, INC. | $245.81 | 2022-2024 | Epclusa |
| Phathom Pharmaceuticals, INC. | $224.50 | 2024 | Voquezna |
| Sight Sciences, INC. | $148.19 | 2022 | |
| Genzyme Corporation | $125.67 | 2025 | |
| Novo Nordisk INC | $125.00 | 2025 | Ozempic |
| Harrow Eye, LLC | $125.00 | 2024 | Vevye |
| Intercept Pharmaceuticals, INC. | $125.00 | 2021 | |
| Lilly USA, LLC | $121.63 | 2024 | Jardiance |
| Exact Sciences Corporation | $119.34 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $114.52 | 2022 | |
| Coopervision INC. | $75.79 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.39 | 2025 | |
| Rayner Intraocular Lenses Limited | $14.92 | 2025 | Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trang Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.